$76.1 Million is the total value of Madryn Asset Management, LP's 4 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ESTA | ESTABLISHMENT LABS HLDGS INC | $39,806,000 | -19.3% | 732,000 | 0.0% | 52.32% | +22.2% | |
SOMALOGIC INC | $33,761,000 | -43.6% | 7,469,202 | 0.0% | 44.38% | -14.7% | ||
SOMALOGIC INC | $1,728,000 | -51.1% | 838,099 | 0.0% | 2.27% | -26.0% | ||
VERO | VENUS CONCEPT INC | $779,000 | -67.6% | 1,680,598 | 0.0% | 1.02% | -50.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ESTABLISHMENT LABS HLDGS INC | 8 | Q3 2023 | 70.6% |
SOMALOGIC INC | 8 | Q3 2023 | 61.1% |
SOMALOGIC INC | 8 | Q3 2023 | 4.1% |
VENUS CONCEPT INC | 6 | Q1 2023 | 2.1% |
GREENBROOK TMS | 3 | Q3 2023 | 9.4% |
VENUS CONCEPT INC | 2 | Q3 2023 | 0.6% |
View Madryn Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Greenbrook TMS Inc. | July 25, 2022 | 2,631,578 | 8.2% |
Venus Concept Inc. | December 18, 2020 | 1,007,441 | 20.3% |
Aquestive Therapeutics, Inc. | December 01, 2020 | 1,530,717 | 4.2% |
View Madryn Asset Management, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-05-16 |
SC 13D/A | 2024-05-13 |
SC 13D/A | 2024-05-08 |
SC 13D/A | 2024-05-07 |
SC 13D/A | 2024-05-01 |
SC 13D/A | 2024-04-08 |
SC 13D/A | 2024-02-22 |
3 | 2024-01-11 |
DFAN14A | 2024-01-05 |
DFAN14A | 2024-01-04 |
View Madryn Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.